SCHEMBL9765682

SCHEMBL9765682

NCCN1CC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6632128 0.97 ALOX15 (0.50)
SCHEMBL12677450 0.82
SCHEMBL4421772 0.82
SCHEMBL4542330 0.81
Hydrochloric Acid SCHEMBL7219443 0.80 MAOA (0.48)
SCHEMBL12128266 0.73
SCHEMBL15760642 0.71 HRH3 (0.43)
SCHEMBL179843 0.69 ALOX15 (1.00)
SCHEMBL3975418 0.69 ALOX15 (1.00)
SCHEMBL242967 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3092901-B1 QUINOLONE ANALOGS AND METHODS RELATED THERETO SENHWA BIOSCIENCES INC (TW) 2020-04-29 EP disclosed
US-9238657-B2 Cephalosporin having catechol group SHIONOGI & CO., LTD. (JP) 2016-01-19 US disclosed
US-9238657-B2 Cephalosporin having catechol group SHIONOGI & CO., LTD. (JP) 2016-01-19 US disclosed
EP-2341053-B1 CEPHALOSPORIN HAVING CATECHOL GROUP SHIONOGI & CO (JP) 2016-01-13 EP disclosed
US-20110190254-A1 CEPHALOSPORIN HAVING CATECHOL GROUP SHIONOGI & CO., LTD. (JP) 2011-08-04 US disclosed
US-20110190254-A1 CEPHALOSPORIN HAVING CATECHOL GROUP SHIONOGI & CO., LTD. (JP) 2011-08-04 US disclosed
EP-2341053-A1 CEPHALOSPORIN HAVING CATECHOL GROUP Shionogi & Co., Ltd. (JP) 2011-07-06 EP disclosed
US-5055569-A Gastrointestinal disorders G. D. SEARLE & CO. (US) 1991-10-08 US disclosed
EP-0423777-A2 Method of treating gastrointestinal motility disorders G.D. Searle & Co. (US) 1991-04-24 EP disclosed
EP-0423776-A2 N-(6)-substituted adenosine compounds G.D. Searle & Co. (US) 1991-04-24 EP disclosed